Sahil Kirpekar - Dec 1, 2022 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Chief Business Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact
Stock symbol
ATAI
Transactions as of
Dec 1, 2022
Transactions value $
$0
Form type
4
Date filed
12/2/2022, 03:20 PM
Previous filing
Dec 2, 2022
Next filing
Mar 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +750K $0.00 750K Dec 1, 2022 Common Shares 750K $3.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest as to 25% of the underlying shares on November 29, 2023, and in 36 substantially equal monthly installments thereafter.